Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture …
| Periodo | 2027-02 | 2025-02 | 2024-10 | 2024-08 |
|---|---|---|---|---|
| Real | — | $0.04 | $0.05 | $0.04 |
| Estimado | — | $0.16 | $0.04 | $0.04 |
| Sorpresa | — | -75.0% | +25.0% | +0.0% |
| Métrica | HLN.L | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 64.2% | 57.4% | +6.8% |
| Operating Margin | 21.9% | -34.4% | +56.3% |
| Net Margin | 15.1% | -32.5% | +47.6% |
| FCF Margin | 21.0% | -12.6% | +33.5% |
| ROE | 10.2% | -39.2% | +49.3% |
| ROA | 5.1% | -30.9% | +36.1% |
| Current Ratio | 0.92 | 2.73 | -1.81 |
| Debt / Equity | 0.47 | 0.28 | +0.19 |
| Tendencia (Piotroski) | FY25 | FY24 |
|---|---|---|
| ✓Rentabilidad sobre activos positiva | 5.1% | — |
| ✓Flujo de caja operativo positivo | £2.6B | £2.3B |
| ✓Rentabilidad sobre activos al alza | 5.1% | 4.2% |
| ✓Caja operativa/activos supera al ROA | 8.1% | ROA 5.1% |
| ✓Menos deuda a largo plazo | 23.8% | 25.2% |
| ✗Mejor liquidez (ratio corriente) | 0.92 | 0.98 |
| ✗Sin aumentar el nº de acciones | — | — |
| ✓Margen bruto al alza | 64.2% | 60.7% |
| ✓Rotación de activos al alza | 0.34 | 0.33 |
| Calidad del negocio | FY25 |
|---|---|
| ✓Margen FCF > 10 % | 21.0% |
| ✗ROCE > 10 % | 8.7% |
| ✗Ventas > 5 %/año (3 años) | 0.5% |
| ✓Deuda neta/EBITDA < 3x | 2.6x |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 5.8% |
HALEON PLC cotiza a 3.76 GBP y tiene una capitalización bursátil de £33.1B. Datos fundamentales de los informes financieros anuales oficiales (ESEF) vía filings.xbrl.org; cuentas anuales, sin trimestrales.Más empresas del sector Salud